NYSE:DNMR Danimer Scientific (DNMR) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free DNMR Stock Alerts $0.80 -0.01 (-1.23%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.78▼$0.8350-Day Range$0.77▼$1.7052-Week Range$0.60▼$3.56Volume433,528 shsAverage Volume845,778 shsMarket Capitalization$91.95 millionP/E RatioN/ADividend YieldN/APrice Target$1.63 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Danimer Scientific alerts: Email Address Danimer Scientific MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside101.9% Upside$1.63 Price TargetShort InterestBearish19.26% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.01Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.92) to ($0.53) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.91 out of 5 starsIndustrial Products Sector160th out of 167 stocksPlastics Materials & Resins Industry11th out of 11 stocks 3.3 Analyst's Opinion Consensus RatingDanimer Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDanimer Scientific has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted19.26% of the outstanding shares of Danimer Scientific have been sold short.Short Interest Ratio / Days to CoverDanimer Scientific has a short interest ratio ("days to cover") of 23.4, which indicates bearish sentiment.Change versus previous monthShort interest in Danimer Scientific has recently increased by 5.36%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldDanimer Scientific does not currently pay a dividend.Dividend GrowthDanimer Scientific does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DNMR. Previous Next 1.1 News and Social Media Coverage News SentimentDanimer Scientific has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Danimer Scientific this week, compared to 1 article on an average week.Search InterestOnly 6 people have searched for DNMR on MarketBeat in the last 30 days. This is a decrease of -65% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Danimer Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -56% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Danimer Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders14.30% of the stock of Danimer Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.84% of the stock of Danimer Scientific is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Danimer Scientific are expected to grow in the coming year, from ($0.92) to ($0.53) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Danimer Scientific is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Danimer Scientific is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDanimer Scientific has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About Danimer Scientific Stock (NYSE:DNMR)Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.Read More DNMR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DNMR Stock News HeadlinesApril 26, 2024 | finance.yahoo.comDanimer Scientific, Inc. (DNMR)April 26, 2024 | finance.yahoo.comIndustry Analysts Just Upgraded Their Danimer Scientific, Inc. (NYSE:DNMR) Revenue Forecasts By 11%April 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 22, 2024 | baystreet.caDainier Ekes Ahead on Mountain Ridge DealApril 22, 2024 | markets.businessinsider.comJefferies Keeps Their Buy Rating on Danimer Scientific (DNMR)April 22, 2024 | businesswire.comDanimer Scientific Announces $20 Million Asset-Based Revolving Credit FacilityApril 9, 2024 | msn.comDanimer Scientific downgraded at Piper Sandler on slower revenue growthApril 6, 2024 | uk.investing.comDanimer shares target cut by TD Cowen, maintain buy ratingApril 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 2, 2024 | finance.yahoo.comDanimer Scientific, Inc. (NYSE:DNMR) Just Reported Earnings, And Analysts Cut Their Target PriceApril 1, 2024 | finance.yahoo.comDanimer Scientific, Inc. (NYSE:DNMR) Q4 2023 Earnings Call TranscriptMarch 31, 2024 | gurufocus.comQ4 2023 Danimer Scientific Inc Earnings Call TranscriptMarch 28, 2024 | benzinga.comRecap: Danimer Scientific Q4 EarningsMarch 28, 2024 | finance.yahoo.comDanimer Scientific Inc (DNMR) Faces Headwinds: Earnings Miss Analyst Expectations Amidst ChallengesMarch 28, 2024 | businesswire.comDanimer Scientific Announces Fourth Quarter and Full Year 2023 ResultsMarch 25, 2024 | businesswire.comDanimer Scientific Announces Closing of $15 Million Registered Direct OfferingMarch 22, 2024 | finance.yahoo.comDanimer Scientific Inc (DNMR) Faces Revenue Decline Amidst Growth in PHA SegmentMarch 21, 2024 | markets.businessinsider.comDanimer Scientific: Strong Buy Rating on Positive Growth and Financial Stability ProjectionsMarch 21, 2024 | markets.businessinsider.comDanimer Scientific Announces $15 Mln Registered Direct OfferingMarch 20, 2024 | businesswire.comDanimer Scientific Announces $15 Million Registered Direct OfferingMarch 17, 2024 | finance.yahoo.comDNMR Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comDNMR Apr 2024 1.500 putMarch 15, 2024 | finance.yahoo.comDNMR Mar 2024 1.000 putMarch 10, 2024 | finance.yahoo.comDNMR Mar 2024 1.500 putMarch 8, 2024 | finance.yahoo.comDNMR Aug 2024 2.000 callFebruary 22, 2024 | finance.yahoo.comDanimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant CapacityFebruary 22, 2024 | businesswire.comDanimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant CapacitySee More Headlines Receive DNMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danimer Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/28/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorIndustrial Products Industry Plastics materials & resins Sub-IndustryN/A Current SymbolNYSE:DNMR CUSIPN/A CIK1779020 Webdanimerscientific.com Phone229-243-7075FaxN/AEmployees271Year FoundedN/APrice Target and Rating Average Stock Price Target$1.63 High Stock Price Target$2.00 Low Stock Price Target$1.25 Potential Upside/Downside+101.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-155,470,000.00 Net Margins-333.03% Pretax Margin-332.35% Return on Equity-49.01% Return on Assets-21.12% Debt Debt-to-Equity Ratio1.37 Current Ratio6.87 Quick Ratio5.26 Sales & Book Value Annual Sales$46.68 million Price / Sales1.97 Cash FlowN/A Price / Cash FlowN/A Book Value$2.70 per share Price / Book0.30Miscellaneous Outstanding Shares114,240,000Free Float97,905,000Market Cap$91.95 million OptionableOptionable Beta1.51 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Stephen E. Croskrey (Age 63)CEO & Chairman of the Board Comp: $887.94kMr. Michael A. Hajost (Age 60)Chief Financial Officer Comp: $393.51kMr. Phillip D. Van Trump (Age 47)Chief Science & Technology Officer Comp: $338.5kMr. Michael Smith (Age 55)Chief Operating Officer Comp: $373.69kRuss ZukowskiVice President of Corporate FinanceJames PalczynskiInvestor Relations OfficerMr. Stephen Albert Martin Esq. (Age 55)Corporate Secretary & Chief Legal Officer Mr. Scott C. Tuten (Age 48)Chief Marketing & Sustainability Officer Comp: $381.64kMr. Anthony L. Austin (Age 66)Chief Human Resource Officer Mr. John A. Dowdy III (Age 51)Senior Vice President of Financial Planning & Analysis Comp: $375.46kMore ExecutivesKey CompetitorsTrinseoNYSE:TSEResearch SolutionsNASDAQ:RSSSWrap TechnologiesNASDAQ:WRAPFitellNASDAQ:FTELAscent IndustriesNASDAQ:ACNTView All CompetitorsInsiders & InstitutionsThomasville National BankBought 99,078 shares on 4/10/2024Ownership: 0.156%Virtu Financial LLCBought 157,085 shares on 2/26/2024Ownership: 0.178%Greenlight Capital Inc.Bought 131,890 shares on 2/15/2024Ownership: 2.680%Teramo Advisors LLCSold 3,250,000 shares on 2/12/2024Ownership: 0.309%Levin Capital Strategies L.P.Bought 63,500 shares on 2/6/2024Ownership: 0.077%View All Insider TransactionsView All Institutional Transactions DNMR Stock Analysis - Frequently Asked Questions Should I buy or sell Danimer Scientific stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danimer Scientific in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DNMR shares. View DNMR analyst ratings or view top-rated stocks. What is Danimer Scientific's stock price target for 2024? 2 brokers have issued 1 year price objectives for Danimer Scientific's stock. Their DNMR share price targets range from $1.25 to $2.00. On average, they expect the company's share price to reach $1.63 in the next year. This suggests a possible upside of 101.9% from the stock's current price. View analysts price targets for DNMR or view top-rated stocks among Wall Street analysts. How have DNMR shares performed in 2024? Danimer Scientific's stock was trading at $1.02 at the beginning of the year. Since then, DNMR shares have decreased by 21.1% and is now trading at $0.8049. View the best growth stocks for 2024 here. Are investors shorting Danimer Scientific? Danimer Scientific saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 22,000,000 shares, an increase of 5.4% from the March 31st total of 20,880,000 shares. Based on an average trading volume of 939,800 shares, the days-to-cover ratio is presently 23.4 days. View Danimer Scientific's Short Interest. When is Danimer Scientific's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our DNMR earnings forecast. How were Danimer Scientific's earnings last quarter? Danimer Scientific, Inc. (NYSE:DNMR) released its quarterly earnings results on Thursday, March, 28th. The company reported ($0.39) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.39). The business had revenue of $10.95 million for the quarter, compared to the consensus estimate of $10.90 million. Danimer Scientific had a negative trailing twelve-month return on equity of 49.01% and a negative net margin of 333.03%. What guidance has Danimer Scientific issued on next quarter's earnings? Danimer Scientific updated its fourth quarter 2023 earnings guidance on Wednesday, March, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10.9 million-$10.9 million, compared to the consensus revenue estimate of $11.6 million. Who are Danimer Scientific's major shareholders? Danimer Scientific's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Thomasville National Bank (0.16%). Insiders that own company stock include Richard J Hendrix, Scott Tuten and Stuart W Pratt. View institutional ownership trends. How do I buy shares of Danimer Scientific? Shares of DNMR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:DNMR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danimer Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
